An autopsy case report of fulminant myocarditis: Following mRNA COVID-19 vaccination.
J Cardiol Cases
; 26(6): 391-394, 2022 Dec.
Article
in English
| MEDLINE | ID: covidwho-1914560
ABSTRACT
There have been few case reports on fatal outcomes in patients with acute myocarditis after mRNA coronavirus disease 2019 (COVID-19) vaccination. In most cases of myocarditis after mRNA COVID-19 vaccination, the myocarditis is mild, and the prognosis is good. Here we report an autopsy case of fulminant myocarditis following mRNA COVID-19 vaccination. Learning objective:
The global distribution of the mRNA coronavirus disease 2019 vaccine requires consideration of appropriate treatment for postvaccination myocarditis. Eosinophil-mediated immunological injury to cardiomyocytes can be involved in the cause of fulminant inflammation from the pathological findings of postvaccination myocarditis.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
J Cardiol Cases
Year:
2022
Document Type:
Article
Affiliation country:
J.jccase.2022.06.006
Similar
MEDLINE
...
LILACS
LIS